← Back

Wire · operational-macro

Six-Month eCOA Timelines Signal Need for Earlier Planning

Published

11 September 2026

Topic

operational-macro

Sectors

MedtechDrug Discovery

Geography

United States

Source

Read at pharmtech.com

Verified

Fusion42 · 11 September 2026 · Fusion42 review

Early collaboration between sponsors and clinical supply partners is crucial to avoid six-month delays in electronic clinical outcome assessment (eCOA) deployment, with in-person site visits and proactive planning helping to prevent costly clinical trial bottlenecks.

This Wire brief sits within Fusion42's coverage of Medtech and Drug Discovery.

◆ The Wire takeaway

You need to engage supply partners for eCOA licensing and deployment earlier in your trial design to avoid costly six-month delays. Getting boots on the ground at clinical sites and depots opens doors to smoother supply operations and faster trial starts.

Coverage

1 source · 11 Sep 2026

Related on Wire

Topics

MedtechDrug Discoveryecoaclinical-trialssupply-chainclinical-supplytrial-delays